Teratogenia por

Tetraciclinas
COHLAN, S. I. D. N. E. Y. Q. (1963). Growth inhibition of prematures receiving tetracycline. American Journal
of Diseases of Children, 105(5), 453. https://doi.org/10.1001/archpedi.1963.02080040455005
Li, Z., Peng, S., Pan, H., Tang, B., Lam, R. W., & Lu, W. W. (2011). Microarchitecture and nanomechanical
properties of trabecular bone after Strontium Administration in osteoporotic goats. Biological Trace
Element Research, 145(1), 39–46. https://doi.org/10.1007/s12011-011-9158-y
Vennila, V., Madhu, V., Rajesh, R., Ealla, K. K., Velidandla, S. R., & Santoshi, S. (2014). Tetracycline-induced
discoloration of deciduous teeth: case series. Journal of international oral health : JIOH, 6(3), 115–119.
Warner, A. J., Hathaway-Schrader, J. D., Lubker, R., Davies, C., & Novince, C. M. (2022). Tetracyclines and
bone: Unclear actions with potentially lasting effects. Bone, 159, 116377.
https://doi.org/10.1016/j.bone.2022.116377
Zakhem, G. A., Motosko, C. C., Mu, E. W., & Ho, R. S. (2019). Infertility and teratogenicity after paternal
exposure to systemic dermatologic medications: A systematic review. Journal of the American Academy of
Dermatology, 80(4), 957–969. https://doi.org/10.1016/j.jaad.2018.09.031

https://www.uptodate.com/contents/tetracyclines